4 Analysts Have This to Say About Trinseo
Analysts have provided the following ratings for Trinseo (NYSE:TSE) within the last quarter:
Looking Into Trinseo’s Recent Short Interest
Trinseo's (NYSE:TSE) short percent of float has risen 5.95% since its last report. The company recently reported that it has 1.43 million shares sold short, which is 3.92% of all regular shares that are available for trading.
Barclays Maintains Equal-Weight on Trinseo, Lowers Price Target to $53
Barclays analyst Duffy Fischer maintains Trinseo (NYSE:TSE) with a Equal-Weight and lowers the price target from $61 to $53.
Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
How Is The Market Feeling About Trinseo S.A. Ordinary Shares?
Trinseo S.A. Ordinary Shares's (NYSE:TSE) short percent of float has risen 4.46% since its last report. The company recently reported that it has 1.37 million shares sold short, which is 3.75% of all regular shares that are available for trading.
Trinseo Q4 EPS $0.83 Misses $1.22 Estimate, Sales $1.30B Beat $1.26B Estimate
Trinseo (NYSE:TSE) reported quarterly earnings of $0.83 per share which missed the analyst consensus estimate of $1.22 by 31.97 percent. This is a 54.89 percent decrease over earnings of $1.84 per share from the same
Earnings Scheduled For February 8, 2022
Companies Reporting Before The Bell
• Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion.
5 Stocks To Watch For November 8, 2021
Some of the stocks that may grab investor focus today are:
Wall Street expects US Foods Holding Corp. (NYSE: USFD) to report quarterly earnings at $0.49 per share on revenue of $7.61 billion before the opening bell. US Foods shares rose 0.4% to $38.70 in after-hours trading.
Trinseo Q3 EPS $2.36 Beats $2.19 Estimate, Sales $1.27B Miss $1.33B Estimate
Trinseo (NYSE:TSE) reported quarterly earnings of $2.36 per share which beat the analyst consensus estimate of $2.19 by 7.76 percent. This is a 17.77 percent decrease over earnings of $2.87 per share from the same period